Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

NCT06710366 is registered in ClinicalTrials.gov with AB Biotek as lead sponsor.

NCT NCT06710366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06710366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of DAO (diamino Oxidase) Deficiency in Newborns
Lead sponsor
AB Biotek
Phase
Observational
Overall status
Completed
Start date
February 28, 2023
Completion date
June 26, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dao genetic variants